Whether we are predisposed to particular diseases may depend to a large extent on variations in our genomes, but the influence on the presentation of certain pathological traits of genetic variants ...

Key market opportunities in the AI-powered rare disease diagnosis domain include leveraging AI for personalized medicine, ...

The most advanced artificial intelligence programs are now capable of significantly accelerating pharmaceutical research by modeling molecular interactions. However, a team from the University ...

Bloomington pilot uses AI and genetic testing to detect familial hypercholesterolemia, a hidden cause of high cholesterol and heart risks in families.

The AI-based method, DeepScence, works to identify senescent cells in the body. These are cells that have stopped dividing ...

Key opportunities in the AI clinical genomics interpretation market include the rising demand for precision medicine, wider ...